NEW YORK (Reuters Health) - As many as 14 percent of people with psoriasis may also have psoriatic arthritis, research shows. Psoriatic arthritis is an autoimmune disorder that combines symptoms of ...

Otezla (apremilast) is an oral tablet commonly used to treat psoriatic arthritis in adults. Psoriatic arthritis is a long-lasting condition that affects the joints in people with psoriasis. Common ...

Early results of an international study examining the risk of arthritis for people with psoriasis have shown a high burden of joint symptoms in 712 patients – 25% of the total studied so far. The ...

Psoriatic arthritis symptoms can be difficult to diagnose, but understanding the causes and available treatment options can ...

Please provide your email address to receive an email when new articles are posted on . Selarsdi is approved for the treatment of plaque psoriasis, psoriatic arthritis in adults, patients aged 6 years ...

This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat various cancers and autoimmune conditions such as rheumatoid arthritis and ...

Depression symptoms are often underdiagnosed and undertreated in patients with psoriasis and psoriatic arthritis, contributing to a worsened quality of life (QOL). However, a recent study found that ...

Please provide your email address to receive an email when new articles are posted on . New EULAR points to consider focus on preventing disease progression to psoriatic arthritis. Slowing disease ...

It can cause lasting joint damage and even disability if left untreated ...

Investigators recently examined clinical risk factors in the context of novel molecular biomarkers to predict progression of psoriasis to PsA. Nail involvement was found to be a strong predictor of ...

One of the more serious side effects from immune checkpoint inhibitor (ICI) therapies for cancer is new-onset or worsened autoimmune diseases. Clinicians have been concerned that conventional ...